Home › Funds › Seven Fleet Capital Management LP › TSHA

Seven Fleet Capital Management LP position in TSHA

TAYSHA GENE THERAPIES INC · Health Care

Seven Fleet Capital Management LP reported holding 1,504,400 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q2 2026 13F filing — a position valued at US$9.9M, representing 1.64% of its reported portfolio and ranking #13 among its reported holdings. Seven Fleet Capital Management LP has disclosed TSHA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.50M sh
Reported value held$9.94M
Portfolio Weight1.64%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Seven Fleet Capital Management LP's TSHA position evolved

Seven Fleet Capital Management LP first disclosed a stake in TSHA in Q4 2025 at 167,223 shares (US$920K). The position peaked in Q2 2026 at 1,504,400 shares, worth US$9.9M. Across 3 filings, Seven Fleet Capital Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,504,400 shares valued at US$9.9M — an increase of 878,692 shares quarter over quarter.. Notable position changes include a 274% increase in Q1 2026 (shares rose 52% over the following quarter), a 140% increase in Q2 2026 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 167.22K $919.73K New
Q1 2026 625.71K $2.80M Add
Q2 2026 1.50M $9.94M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSHA and 13F data

TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 56 other funds we track also report a position in TSHA — the largest reported positions include Avoro Capital Advisors LLC (US$162.7M), RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSHA

All TSHA fund holders →

FAQ

How long has Seven Fleet Capital Management LP held TSHA?

Seven Fleet Capital Management LP has disclosed TSHA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Seven Fleet Capital Management LP's current position in TSHA?

As of Q2 2026, Seven Fleet Capital Management LP holds 1.50M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $9.94M, representing 1.64% of its reported portfolio and ranking #13.

Has Seven Fleet Capital Management LP been buying or selling TSHA?

In the latest 13F filing (Q2 2026), Seven Fleet Capital Management LP increased its position in TSHA. The position peaked in Q2 2026 at 1.50M shares.

Which other funds hold TSHA?

Other major institutional holders of TSHA include Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.